Associated tags: Cloud, Automation, Research, Science, Biotechnology, Software, Health, Pharmaceutical industry, Pharmaceutical, Data Management, Project management office, Lodestar, Intelligence, Drug development, Protein engineering, Fine chemical, Synthetic biology, Drug discovery, University
Locations: MENLO PARK, SAN DIEGO, OREGON, CALIFORNIA, UNITED STATES, NORTH AMERICA
Research,
Technology,
Software,
Biotechnology,
General Health,
Pharmaceutical,
Health,
Data Management,
Science,
Other Science,
Project management office,
Lodestar,
Intelligence,
Partner,
FAIR,
Automation,
Fine chemical In line with this shift, Strateos is reorganizing and expanding its business to focus on design-and-deployment engagements.
Key Points:
- In line with this shift, Strateos is reorganizing and expanding its business to focus on design-and-deployment engagements.
- Disrupting an established industry often requires the flexibility to pivot toward demand, which for biopharmaceutical customers is creating state-of-the-art on-site cloud labs,” said Mark Fischer-Colbrie, Strateos Chief Executive Officer.
- “The urgent need for transformation combined with the opportunity of artificial intelligence is driving demand for Strateos LodeStar software and our design and deployment capabilities.
- These strategies support the growing demand from the company’s customers who are seeking laboratory modernization and transformation solutions.
Retrieved on:
Wednesday, February 8, 2023
Technology,
Research,
Software,
Biotechnology,
Health,
Robotics,
Pharmaceutical,
Science,
Artificial Intelligence,
Project management office,
Software as a service,
Roger W. Jones Award for Executive Leadership,
CFO,
Cornell University,
BIOL,
SoftBank Group,
Synthetic biology,
Professional degrees of public health,
Protein engineering,
Workflow,
Investment,
Otorhinolaryngology,
Drexel University,
Master,
Syneos Health,
AROS Research Operating System,
Drug development,
Patent,
Patient,
Harvard Medical School,
University,
CFA,
Lodestar,
Intelligence,
Lazard,
Wall Street,
Growth,
Public health,
MPH,
Multimedia,
Wyeth,
Drug discovery,
AstraZeneca,
Biophysics,
BS,
Albany Medical College,
Management,
Pharmaceutical industry,
Pfizer,
Biology,
Bioethics,
MD Strateos, Inc., a pioneer in the development of remote access laboratories and lab automation software for life science research, today announced the appointment of Alexander K. Arrow, MD, CFA, as Chief Financial Officer.
Key Points:
- Strateos, Inc., a pioneer in the development of remote access laboratories and lab automation software for life science research, today announced the appointment of Alexander K. Arrow, MD, CFA, as Chief Financial Officer.
- View the full release here: https://www.businesswire.com/news/home/20230208005324/en/
Strateos appoints Alexander K. Arrow as Chief Financial Officer.
- (Photo: Business Wire)
"We are thrilled to welcome Alex and Juliet to the Strateos team.
- He comes to Strateos from commercial-stage medical technology manufacturer Carlsmed, Inc., where he was the Chief Financial Officer.
Data Management,
Health,
Technology,
Software,
Research,
Science,
Biotechnology,
Cloud,
Method,
Synthetic biology,
Automation,
Protein engineering,
Product management,
Drug design,
Workcell,
Communication,
DMTA,
Centralisation,
Solution,
SAR,
Fine chemical,
Pharmaceutical industry,
Instrumentation Strateos continues to introduce flexible solutions for drug discovery teams seeking state-of-the-art ways to advance small molecule programs, said John Harman, Sr. Director of Product Management at Strateos.
Key Points:
- Strateos continues to introduce flexible solutions for drug discovery teams seeking state-of-the-art ways to advance small molecule programs, said John Harman, Sr. Director of Product Management at Strateos.
- The on-demand, scalable Strateos Cloud Lab Automation-as-a-Service Platform features connected robotic automation utilizing 23 workcells and hundreds of instruments.
- Strateos is a pioneer in the development of remote access laboratories and lab automation software for life science discovery.
- The Strateos Cloud Lab Automation-as-a-Service Platform helps scientists more efficiently and reproducibly design, run, and analyze experiments to achieve new and faster scientific discoveries.
Retrieved on:
Thursday, January 6, 2022
Software,
Research,
Networks,
Internet,
Pharmaceutical,
Data Management,
Technology,
Genetics,
Science,
Biotechnology,
Other Technology,
Health,
Knowledge,
Drug discovery,
AI,
Princeton University,
University,
Doctor of Philosophy,
Physical chemistry,
Therapy,
Coronavirus Scientific Advisory Board (Turkey),
GSK,
Automation,
Merck,
Genomics,
Drug development,
Machine learning,
Multimedia,
Industry,
NIH,
Medical device,
Pharmaceutical industry Strateos, Inc., a pioneer in the development of remote access laboratories and lab control software for life science research, today announced the appointment of Tom Rush, PhD to the companys Scientific Advisory Board.
Key Points:
- Strateos, Inc., a pioneer in the development of remote access laboratories and lab control software for life science research, today announced the appointment of Tom Rush, PhD to the companys Scientific Advisory Board.
- We are pleased to welcome Tom to our Scientific Advisory Board where his knowledge and passion for drug discovery will be invaluable as Strateos continues to bring new products to market and engage with biopharma R&D organizations, said Mark Fischer-Colbrie, Chief Executive Officer at Strateos.
- Strateos is a pioneer in the development of remote access laboratories and lab control software for life science discovery.
- The Strateos platform helps scientists more efficiently and reproducibly design, run, and analyze experiments to achieve new and faster scientific discoveries.
Technology,
Research,
Software,
Biotechnology,
Internet,
Health,
Pharmaceutical,
Data management,
Science,
Lizbeth Goodman,
Academic disciplines,
Academia With the SmartLab Software, laboratories will have the ability to toggle between on-site facility control and Strateos remote-controlled SmartLab Studios, advancing the digitization of laboratories via the industrys only hybrid lab solution.
Key Points:
- With the SmartLab Software, laboratories will have the ability to toggle between on-site facility control and Strateos remote-controlled SmartLab Studios, advancing the digitization of laboratories via the industrys only hybrid lab solution.
- Our SmartLab software is the only solution focused on accelerating discovery by connecting the on-site life science R&D lab with an ecosystem of remote-controlled facilities.
- Strateos SmartLab Software will help scientists define and execute their scientific workflows both on-site and off-site from a single software interface fundamentally transforming the way life science is being conducted.
- Strateos is a pioneer in the development of remote access laboratories and lab control software for life science discovery.
Science,
Software,
Biotechnology,
Research,
Pharmaceutical,
Health,
Data management,
Technology,
Lizbeth Goodman,
Automation,
Academic disciplines,
Academia With this financing, Strateos will continue to drive innovations on its SmartLab Platform, which integrates data generation and AI-enablement with its unique and flexible automation to accelerate pharmaceutical and synthetic biology R&D.
Key Points:
- With this financing, Strateos will continue to drive innovations on its SmartLab Platform, which integrates data generation and AI-enablement with its unique and flexible automation to accelerate pharmaceutical and synthetic biology R&D.
- Life science research needs faster, more reliable and lower cost data to fully leverage artificial intelligence-powered analysis tools, said Mark Fischer-Colbrie, CEO at Strateos.
- With their support, Strateos is re-imagining the world of life science research and ushering in a new era of decentralized discovery.
- The Strateos SmartLab Platform helps scientists more efficiently and reproducibly design, run, and analyze experiments to achieve new and faster scientific discoveries.
